このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Ideas Moving Parents and Adolescents to Change Together (IMPACT) (IMPACT)

2020年8月13日 更新者:Elaine Borawski、Case Western Reserve University

Targeting Obesity and Blood Pressure in Urban Youth(Consortium Title: Childhood Obesity Prevention and Treatment Research [COPTR] and Site Project Name IMPACT (Ideas Moving Parents and Adolescents to Change Together).

The National Heart, Lung, and Blood Institute (NHLBI) of the National Institute of Health (NIH) has sponsored a consortium of four sites across the United States, entitled Childhood Obesity Prevention and Treatment Research (COPTR). Each site has its own protocol. Case Western Reserve/Cleveland's project is entitled "Targeting Obesity and Blood Pressure in Urban Youth". The site name is IMPACT (Ideas Moving Parents and Adolescents to Change Together).

The project assesses the effects of three interventions on Body Mass Index(BMI) in overweight and obese urban 5th-8th grade youth: a cognitive-behavioral intervention (HealthyChange), a systems improvement intervention (SystemsChange), and an education-only intervention (Tools4Change). In addition the study assesses the potential additional impact of a school-community based intervention on outcomes.

The project has two phases: a formative phase (including focus groups and a pilot) and the main trial. The main trial will take place over approximately four years.

調査の概要

詳細な説明

The IMPACT trial will involve a 3-arm randomized controlled trial of three behavioral and educational interventions: (1) HealthyCHANGE, a behavioral approach focusing on building skills and increasing intrinsic motivation (based on cognitive-behavioral theory with motivational interviewing components); (2) SystemCHANGE, an innovative behavioral approach focusing on system re-design of the family environment and daily routines (based on social-ecological and personal process improvement theories); and (3) education-only (representing usual care, called Tools4CHANGE).

In the main trial, approximately half of the children will also be in schools that take part in the We Run This City (WRTC)Marathon program, a school-based fitness program administered by the YMCA, and half will be in schools that do not take part in the WRTC program.

This study will assess the impact of the interventions on the main trial's (1) primary outcome, Change in Body Mass Index (BMI). (2) secondary outcomes including diet, physical activity, sedentary behavior, sleep, blood pressure, cardiovascular risk, body composition, fitness, and quality of life (3) mediators including : child's self-efficacy, social support, motivation, family problem solving ability, systems thinking, and self-regulation;(4) moderators including: socioeconomic status, demographic factors, environmental factors, personal and psychosocial characteristics of child and parent.

研究の種類

介入

入学 (実際)

360

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

    • Ohio
      • Cleveland、Ohio、アメリカ、44106
        • Case Western Reserve University

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

11年~15年 (子)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion Criteria:

  • Students entering the 6th grade who are found at the standard school screenings to be overweight or obese
  • (BMI 85th- 94th percentile or > 95th percentile for age/sex respectively)

Exclusion Criteria:

  • Taking medications that alter appetite or weight (e.g. glucocorticoids, metformin, insulin, Risperidone (Risperdal), Olanzapine (Zyprexa), Clozapine(Clozaril), Quetiapine (Seroquel), Ziprasidone (Geodon), Carbamazepine (Tegretol), Valproic acid (Depakote/Depakene/Depacon), Aripiprazole (Abilify), Orlistat (Xenical), Sibutramine (Meridia), Phentermine, Diethylproprion (Tenuate), Topirimate (Topamax), glitazones (thiazolidinediones)
  • Inability to understand English
  • Stage 2 hypertension or stage 1 hypertension with end organ damage (left ventricular hypertrophy, microalbuminuria)
  • Severe behavioral problems that preclude group participation (as reported by parent/guardian)
  • Child involvement in another weight management program
  • Family expectation to move from the region within 1 year
  • The presence of a known medical condition that itself causes obesity (e.g., Prader-Willi syndrome) or interfere with HbA1C ( sickle cell disease)

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:独身

武器と介入

参加者グループ / アーム
介入・治療
実験的:HealthyCHANGE
Cognitive behavioral strategies to address diet, physical activity, sedentary behavior and sleep for children.

Cognitive behavioral strategies to address diet, physical activity, sedentary behavior and sleep for children.

It involves an intensive series of group sessions, followed by rotating monthly face-to-face meetings or phone calls.

実験的:SystemCHANGE
Intervention (based on systems improvement and choice architecture theories) System improvement and choice architecture theories seek to teach a set of skills using family self-designed experiments to redesign daily routines

Intervention (based on systems improvement and choice architecture theories) System improvement and choice architecture theories seek to teach a set of skills using family self-designed experiments to redesign daily routines regarding eating, activity and sleep.

It involves an intensive series of group sessions, followed by rotating monthly face-to-face meetings or phone calls.

介入なし:Tools4CHANGE
In contrast to the behavioral arms, youths with their parent(s)/guardian randomized to this group will have one 60-minute face-to-face meeting at initiation of the study with a dietitian who is also trained in recommendations for exercise and sedentary behavior.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Slope of Body Mass Index (BMI)
時間枠:Baseline, 12 mos, 24 mos and 36 mos
BMI slope (trajectory over 3 years) was created for each participant with outcomes multiply imputed for children without BMI values post-baseline. An F test with two numerator degrees of freedom was used to test for between-group differences using an alpha of .05.
Baseline, 12 mos, 24 mos and 36 mos

二次結果の測定

結果測定
メジャーの説明
時間枠
Dietary Intake- Calories Per Day
時間枠:Baseline, 12 mos, 24 mos and 36 mos

Annualized change in calories per day.

Dietary intake slopes (trajectory over 3 years) were created for each participant with outcomes multiply imputed for children without diet recall data post-baseline. An F test with two numerator degrees of freedom was used to test for between-group differences using an alpha of .05.

Baseline, 12 mos, 24 mos and 36 mos
Blood Pressure
時間枠:Baseline, 12 mos, 24 mos and 36 mos

Annualized change in blood pressure measures using the slope of 3 year trajectory.

Blood pressure slopes (trajectory over 3 years) were created for each participant with outcomes multiply imputed for children without blood pressure readings post-baseline. An F test with two numerator degrees of freedom was used to test for between-group differences using an alpha of .05.

Baseline, 12 mos, 24 mos and 36 mos
Physical Activity
時間枠:[Baseline, 12 mos, 24 mos and 36 mos]

Annualized change in physical activity measures of moderate to vigorous minutes per day and bed rest/sedentary minutes per day as measured by accelerometer.

Physical activity slopes (trajectory over 3 years) were created for each participant with outcomes multiply imputed for children without accelerometer readings post-baseline. An F test with two numerator degrees of freedom was used to test for between-group differences using an alpha of .05.

[Baseline, 12 mos, 24 mos and 36 mos]
Sleep
時間枠:[Baseline, 12 mos, 24 mos and 36 mos]

The results reflect the annualized change in adolescent sleep wake scale and pediatric daytime sleepiness scale. The items of the adolescent sleep wake scale are recoded to have a minimum of 0 and maximum value of 5, in which a higher scores for both the individual items and the overall sum score indicate a better outcome. The items of the pediatric daytime sleepiness are recoded to have a minimum of 0 and maximum value of 4, in which a lower score for both the individual items and the overall sum score indicates a better outcome.

Sleep slopes (trajectory over 3 years) were created for each participant with outcomes multiply imputed for children without post-baseline measures. An F test with two numerator degrees of freedom was used to test for between-group differences using an alpha of .05.

[Baseline, 12 mos, 24 mos and 36 mos]
Cardiometabolic Factors- Fasting Glucose, HDL Cholesterol, LDL Cholesterol, Total Cholesterol
時間枠:Baseline, 12 mos, 24 mos and 36 mos

Annualized change in various cardiometabolic factor measures over 3 years.

Cardiometabolic factor slopes (trajectory over 3 years) were created for each participant with outcomes multiply imputed for children without blood draws post-baseline. An F test with two numerator degrees of freedom was used to test for between-group differences using an alpha of .05.

Change in the slopes of fasting glucose, HDL cholesterol, LDL cholesterol, and total cholesterol over 3 years reported.

Baseline, 12 mos, 24 mos and 36 mos
Body Composition- BMI Percentile
時間枠:Baseline, 12 mos, 24 mos and 36 mos

The annualized change in body composition measures over 3 years.

Body composition slopes (trajectory over 3 years) were created for each participant with outcomes multiply imputed for children without body composition measurements post-baseline. An F test with two numerator degrees of freedom was used to test for between-group differences using an alpha of .05.

Change in slope of BMI percentile over time reported.

Baseline, 12 mos, 24 mos and 36 mos
Fitness
時間枠:Baseline, 12 mos, 24 mos and 36 mos

The annualized change in pacer laps completed during PACER test over 3 years.

PACER test slopes (trajectory over 3 years) were created for each participant with outcomes multiply imputed for children without PACER test measurements post-baseline. An F test with two numerator degrees of freedom was used to test for between-group differences using an alpha of .05.

Baseline, 12 mos, 24 mos and 36 mos
Quality of Life- Perceived Stress
時間枠:[Baseline, 12 mos, 24 mos and 36 mos]

The annualized change in perceived stress over 3 years. Participants are asked to rate individual scale items on their perception of how often they feel specific stressors on a scale from 0 (never) to 4 (very often). Individual scale items are summed for a total score. Higher scores indicate higher perceived frequency of stressors, therefore higher perceived stress. Outcomes are reported as the mean of the slope estimates for total perceived stress score over 3 years (from baseline to 36 months).

The perceived stress slope (trajectory over 3 years) was created for each participant with outcomes multiply imputed for children without stress scores post-baseline. An F test with two numerator degrees of freedom was used to test for between-group differences using an alpha of .05.

[Baseline, 12 mos, 24 mos and 36 mos]
Dietary Intake- Percent Calories From Fat
時間枠:Baseline, 12 months, 24 months, 36 months

The annualized change of percent of calories from fat over 3 years.

Percent calories from fat slope (trajectory over 3 years) was created for each participant with outcomes multiply imputed for children without diet recall data post-baseline. An F test with two numerator degrees of freedom was used to test for between-group differences using an alpha of .05.

Baseline, 12 months, 24 months, 36 months
Dietary Intake- Fruit and Vegetable Servings
時間枠:Baseline, 12 months, 24 months, 36 months

The annualized change in the number of fruit and vegetable servings per day over 3 years.

Serving slopes (trajectory over 3 years) were created for each participant with outcomes multiply imputed for children without diet recall data post-baseline. An F test with two numerator degrees of freedom was used to test for between-group differences using an alpha of .05.

Baseline, 12 months, 24 months, 36 months
Dietary Intake- Sodium
時間枠:Baseline, 12 months, 24 months, 36 months

The annualized change in sodium intake (mg) per day over 3 years.

Sodium intake slope (trajectory over 3 years) was created for each participant with outcomes multiply imputed for children without diet recall data post-baseline. An F test with two numerator degrees of freedom was used to test for between-group differences using an alpha of .05.

Baseline, 12 months, 24 months, 36 months
Cardiometabolic Factors- Hemoglobin A1c
時間枠:[Baseline, 12 mos, 24 mos, 36 mos]

Annualized change in various cardiometabolic factor measures over 3 years.

Cardiometabolic factor slopes (trajectory over 3 years) were created for each participant with outcomes multiply imputed for children without blood draws post-baseline. An F test with two numerator degrees of freedom was used to test for between-group differences using an alpha of .05.

Change in the slope of glycated Hemoglobin A1c over 3 years reported.

[Baseline, 12 mos, 24 mos, 36 mos]
Cardiometabolic Factors- High-sensitivity C-reactive Protein
時間枠:[Baseline, 12 mos, 24 mos, 36 mos]

Annualized change in various cardiometabolic factor measures over 3 years.

Cardiometabolic factor slopes (trajectory over 3 years) were created for each participant with outcomes multiply imputed for children without blood draws post-baseline. An F test with two numerator degrees of freedom was used to test for between-group differences using an alpha of .05.

Change in the slope of high-sensitivity C-reactive protein over 3 years reported.

[Baseline, 12 mos, 24 mos, 36 mos]
Cardiometabolic Factors- Insulin
時間枠:[Baseline, 12 mos, 24 mos, 36 mos]

Annualized change in various cardiometabolic factor measures over 3 years.

Cardiometabolic factor slopes (trajectory over 3 years) were created for each participant with outcomes multiply imputed for children without blood draws post-baseline. An F test with two numerator degrees of freedom was used to test for between-group differences using an alpha of .05.

Change in the slope of insulin over 3 years reported.

[Baseline, 12 mos, 24 mos, 36 mos]
Cardiometabolic Factors- HOMA-IR
時間枠:[Baseline, 12 mos, 24 mos, 36 mos]

Annualized change in various cardiometabolic factor measures over 3 years.

Cardiometabolic factor slopes (trajectory over 3 years) were created for each participant with outcomes multiply imputed for children without blood draws post-baseline. An F test with two numerator degrees of freedom was used to test for between-group differences using an alpha of .05.

Change in the slope of HOMA-IR over 3 years reported.

[Baseline, 12 mos, 24 mos, 36 mos]
Body Composition- Waist-to-height Ratio
時間枠:[Baseline, 12 mos, 24 mos, 36 mos]

The annualized change in body composition measures over 3 years.

Body composition slopes (trajectory over 3 years) were created for each participant with outcomes multiply imputed for children without body composition measurements post-baseline. An F test with two numerator degrees of freedom was used to test for between-group differences using an alpha of .05.

Change in slope of waist-to-height ratio over time reported. The weight-to-heigh ratio compares the child's waist circumference (cm) to their height (cm).

[Baseline, 12 mos, 24 mos, 36 mos]
Body Composition- Waist Circumference
時間枠:[Baseline, 12 mos, 24 mos, 36 mos]

The annualized change in body composition measures over 3 years.

Body composition slopes (trajectory over 3 years) were created for each participant with outcomes multiply imputed for children without body composition measurements post-baseline. An F test with two numerator degrees of freedom was used to test for between-group differences using an alpha of .05.

Change in slope of waist circumference (cm) over time reported.

[Baseline, 12 mos, 24 mos, 36 mos]
Body Composition- Percent Body Fat
時間枠:[Baseline, 12 mos, 24 mos, 36 mos]

The annualized change in body composition measures over 3 years.

Body composition slopes (trajectory over 3 years) were created for each participant with outcomes multiply imputed for children without body composition measurements post-baseline. An F test with two numerator degrees of freedom was used to test for between-group differences using an alpha of .05.

Change in slope of body fat percentage over time reported. Body fat percentage calculated using Stevens equation.

[Baseline, 12 mos, 24 mos, 36 mos]

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

捜査官

  • 主任研究者:Elaine A Borawski, PhD、Case Western Reserve University
  • 主任研究者:Shirley M Moore, RN, PhD、Case Western Reserve University

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

一般刊行物

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2011年2月1日

一次修了 (実際)

2017年1月21日

研究の完了 (実際)

2017年1月31日

試験登録日

最初に提出

2011年12月20日

QC基準を満たした最初の提出物

2012年1月17日

最初の投稿 (見積もり)

2012年1月23日

学習記録の更新

投稿された最後の更新 (実際)

2020年8月25日

QC基準を満たした最後の更新が送信されました

2020年8月13日

最終確認日

2020年8月1日

詳しくは

本研究に関する用語

追加の関連 MeSH 用語

その他の研究ID番号

  • IMPACT-1-5U01HL103622-02
  • 5U01HL103622-02 (米国 NIH グラント/契約)

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

はい

IPD プランの説明

Conducted in conjunction with the Research Coordinating Unit (UNC Chapel Hill) of the COPTR Consortium.

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

米国で製造され、米国から輸出された製品。

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

3
購読する